Carmen Jacob

1.1k total citations
20 papers, 763 citations indexed

About

Carmen Jacob is a scholar working on Epidemiology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carmen Jacob has authored 20 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Neurology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carmen Jacob's work include Neuroendocrine Tumor Research Advances (8 papers), Neuroblastoma Research and Treatments (7 papers) and Lung Cancer Research Studies (3 papers). Carmen Jacob is often cited by papers focused on Neuroendocrine Tumor Research Advances (8 papers), Neuroblastoma Research and Treatments (7 papers) and Lung Cancer Research Studies (3 papers). Carmen Jacob collaborates with scholars based in United States, United Kingdom and Germany. Carmen Jacob's co-authors include James C. Yao, Alexandria T. Phan, Kenneth R. Hess, Funda Meric‐Bernstam, David Z. Chang, Jeannette E. Mares, Robert A. Wolff, Sanjay Gupta, Asif Rashid and Chaan S. Ng and has published in prestigious journals such as Journal of Clinical Oncology, Stroke and Scientific Reports.

In The Last Decade

Carmen Jacob

19 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Jacob United States 9 566 536 401 154 76 20 763
Ben Lawrence New Zealand 15 947 1.7× 931 1.7× 566 1.4× 175 1.1× 58 0.8× 47 1.2k
Deepti Singh India 8 203 0.4× 240 0.4× 159 0.4× 127 0.8× 102 1.3× 14 460
Teodora Kolarova United States 12 197 0.3× 226 0.4× 138 0.3× 122 0.8× 29 0.4× 31 452
Concetta Sciammarella Italy 15 284 0.5× 412 0.8× 164 0.4× 118 0.8× 45 0.6× 24 709
Veronica Tavaglione Italy 8 216 0.4× 258 0.5× 132 0.3× 67 0.4× 99 1.3× 8 460
Viktor Johanson Sweden 20 621 1.1× 542 1.0× 446 1.1× 114 0.7× 67 0.9× 43 1.0k
Marco Schiavo Lena Italy 14 315 0.6× 446 0.8× 156 0.4× 42 0.3× 77 1.0× 56 548
Johanna M. Zuetenhorst Netherlands 9 390 0.7× 309 0.6× 317 0.8× 32 0.2× 33 0.4× 15 471
Jonas Schumacher Germany 4 301 0.5× 228 0.4× 169 0.4× 109 0.7× 60 0.8× 7 590
Jacklynn V. Egger United States 12 307 0.5× 714 1.3× 69 0.2× 230 1.5× 368 4.8× 30 941

Countries citing papers authored by Carmen Jacob

Since Specialization
Citations

This map shows the geographic impact of Carmen Jacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Jacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Jacob more than expected).

Fields of papers citing papers by Carmen Jacob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Jacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Jacob. The network helps show where Carmen Jacob may publish in the future.

Co-authorship network of co-authors of Carmen Jacob

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Jacob. A scholar is included among the top collaborators of Carmen Jacob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Jacob. Carmen Jacob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varatharaj, Aravinthan, Carmen Jacob, Angela Darekar, et al.. (2024). Measurement variability of blood–brain barrier permeability using dynamic contrast-enhanced magnetic resonance imaging. Imaging Neuroscience. 2. 1–16. 1 indexed citations
2.
Jacob, Carmen, et al.. (2024). Mild Systemic Inflammation Increases Erythrocyte Fragility. International Journal of Molecular Sciences. 25(13). 7027–7027. 5 indexed citations
3.
Jacob, Carmen, et al.. (2024). Erythrocyte deformability correlates with systemic inflammation. Blood Cells Molecules and Diseases. 109. 102881–102881. 2 indexed citations
4.
Goussard, Pierre, Carmen Jacob, Savvas Andronikou, et al.. (2024). Severe airway obstruction due to pulmonary tuberculosis in a premature infant needing decompression of mediastinal lymph nodes. Pediatric Pulmonology. 59(12). 3739–3742.
5.
Jacob, Carmen, et al.. (2023). Placebo effects on nausea and motion sickness are resistant to experimentally-induced stress. Scientific Reports. 13(1). 4 indexed citations
6.
Jacob, Carmen, et al.. (2021). Malignant middle cerebral artery syndrome with thrombotic thrombocytopenia following vaccination against SARS-CoV-2. Journal of the Intensive Care Society. 23(4). 479–484. 4 indexed citations
7.
Ferguson, Sherise D., Tiffany R. Hodges, Nazanin Majd, et al.. (2020). A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram. Neuro-Oncology Advances. 3(1). 15 indexed citations
8.
Meißner, Karin, et al.. (2019). Individual Factors Contributing to Nausea in First-Time Chemotherapy Patients: A Prospective Cohort Study. Frontiers in Pharmacology. 10. 410–410. 10 indexed citations
9.
Liberman, Ava L., Jean M. Luciano, Zachary Roberts, et al.. (2018). Abstract WP294: Randomized Trial of an Attending Nurse Model of Care for Acute Stroke. Stroke. 49(Suppl_1). 1 indexed citations
10.
Jacob, Carmen, et al.. (2017). Stress changes how we think – Psychophysiological evidence for the Stress-Induced Deliberation to Intuition (SIDI)-model. Psychoneuroendocrinology. 83. 13–13. 1 indexed citations
11.
Reddy, Sangeetha M., Scott Kopetz, Jeffrey S. Morris, et al.. (2015). Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer. Investigational New Drugs. 33(4). 977–984. 33 indexed citations
12.
DeWire, Mariko, Maryam Fouladi, David C. Turner, et al.. (2015). An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN). Journal of Neuro-Oncology. 123(1). 85–91. 43 indexed citations
13.
Yao, James C., Alexandria T. Phan, Kenneth R. Hess, et al.. (2014). Perfusion Computed Tomography as Functional Biomarker in Randomized Run-In Study of Bevacizumab and Everolimus in Well-Differentiated Neuroendocrine Tumors. Pancreas. 44(2). 190–197. 42 indexed citations
14.
15.
Jacob, Carmen, Alexandria T. Phan, Robert A. Wolff, Funda Meric‐Bernstam, & James C. Yao. (2010). Early CgA Response as Predictor of Outcome Following Everolimus Therapy Among Patients With Low- to Intermediate- Grade Neuroendocrine Carcinoma. Pancreas. 39(2). 273–273. 3 indexed citations
16.
Jacob, Carmen. (2009). Neuroendocrine Tumors: Nursing Implications for Oral Targeted Agents and Patient Management: Part II. Clinical journal of oncology nursing. 13(2). 149–153. 1 indexed citations
17.
Jacob, Carmen. (2009). Neuroendocrine Tumors A Rare Finding: Part I. Clinical journal of oncology nursing. 13(1). 21–23. 4 indexed citations
18.
Yao, James C., Alexandria T. Phan, David Z. Chang, et al.. (2008). Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study. Journal of Clinical Oncology. 26(26). 4311–4318. 495 indexed citations
19.
Yao, James C., Alexandria T. Phan, David Z. Chang, et al.. (2007). Phase II study of RAD001 (everolimus) and depot octreotide (sandostatin LAR) in advanced low grade neuroendocrine carcinoma (LGNET). Journal of Clinical Oncology. 25(18_suppl). 4503–4503. 19 indexed citations
20.
Yao, James C., Alexandria T. Phan, David Z. Chang, et al.. (2006). Phase II study of RAD001 (everolimus) and depot octreotide (Sandostatin LAR) in patients with advanced low grade neuroendocrine carcinoma (LGNET). Journal of Clinical Oncology. 24(18_suppl). 4042–4042. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ben Lawrence Breakdown of academic impact, for papers by Deepti Singh Breakdown of academic impact, for papers by Teodora Kolarova Breakdown of academic impact, for papers by Concetta Sciammarella Breakdown of academic impact, for papers by Veronica Tavaglione Breakdown of academic impact, for papers by Viktor Johanson Breakdown of academic impact, for papers by Marco Schiavo Lena Breakdown of academic impact, for papers by Johanna M. Zuetenhorst Breakdown of academic impact, for papers by Jonas Schumacher Breakdown of academic impact, for papers by Jacklynn V. Egger
Rankless by CCL
2026